// App-Quantinova.ai

: A survey of children’s interstitial lung disease (ChILD) databases across the EU and an ability to identify pan-registry clinical trial cohorts

Researchers

Presenter

  • Julia Carlens

Principal Investigators

  • Nicola Ullmann

  • Eitan Kerem

  • Nadia Nathan

  • Ralph Epaud

  • Annick Clement

  • Matthias Griese

  • Deborah Snijders

  • Steve Cunningham

Medical Centers

  • Paediatric Pulmonology, Allergy and Neonatology, Hanover Medical School, Hanover, Germany

  • UOC Broncopneumologia, Dipartimento Pediatrico Universitario Ospedaliero, Ospedale Pediatrico Bambino Gesù – IRCCS, Rome, Italy

  • Department of Pediatrics and Pediatric Pulmonology, Hadassah Hebrew University Medical Center, Jerusalem, Israel

  • Pediatric Pulmonology Department, Reference centre for rare lung diseases RespiRare and Inserm UMR_S933, Trousseau Hospital, APHP and Sorbonne University, Paris, France

  • Pediatric Dept, Centre Intercommunal de Créteil, Créteil, France and Inserm, Unité 955, Equipe 5, Créteil, Créteil, France

  • Dr. von Hauner Children's Hospital, Ludwig-Maximilians-Universitat (LMU), Munich, Germany

  • Dipartimento di Salute della Donna e del Bambino, Universit di Padova, Padova, Italy

  • Centre for Inflammation Research, University of Edinburgh; European Network for translational research in children’s and adult interstitial lung disease COST Action CA16125 and European Respiratory Society ChILD Clinical Research Collaboration, Edinburgh, United Kingdom

Locations

  • Germany

  • Italy

  • Israel

  • France

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Interstitial lung disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved